Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference 2022-01-05 20:45
IMTE raise funds to support the acquisition and building out of manufacturing infrastructure 2022-01-05 20:44
IMTE to divest its Lamination Glass operation in China 2022-01-04 21:26
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines 2021-12-22 19:00
First Patient Dosed in Australia in ATG-101 First-in-Human Trial 2021-12-20 10:56
Bionomics Limited Announces Pricing of Initial Public Offering in the United States 2021-12-16 19:00
Awards and Demand for Process Automation Software Propels Nintex into 2022 2021-12-16 06:05
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes 2021-12-15 21:01
Info-Tech Research Group Reveals 2022 Tech Trends 2021-12-15 06:00
App Annie and AppsFlyer's State of App Marketing report Explores the Rise of the 'App Tourist' in ANZ 2021-12-15 05:00
Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial 2021-12-14 20:25
CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd 2021-12-14 14:59
KAZIA THERAPEUTICS APPOINTS KAREN KRUMEICH AS CHIEF FINANCIAL OFFICER 2021-12-14 00:00
JustGiving® from Blackbaud® is Now Fully Fee-Free for Australian Charity Organisations 2021-12-13 06:00
Ironbark Raises $4m to Continue Citronen Project Finance Activity in 2022 2021-12-10 12:40
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
US EXIM Bank Issues Ironbark Zinc (ASX:IBG) with Preliminary Funding Approval 2021-12-08 10:36
Wise-Sync Settles Legal Claims with NVoiceFlow 2021-12-07 14:16
2021 Imperial Springs International Forum Opened in Guangzhou, China 2021-12-07 12:25
Ho Ho (Oh No!) 2021's Hardest Holiday Conversation: Covid Testing Card Campaign Launches to Humorously Handle Australians' Most Uncomfortable Holiday Ask 2021-12-07 07:38
1 24 25 26 27 28 113